BMRN vs DECK · P/E 40, rev $2.85B vs P/E 16, rev $4.99B
Biomarin Pharmaceutical Inc (BMRN) versus Deckers Outdoor Corporation (DECK) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Deckers Outdoor Corporation (DECK) is a footwear & accessories company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported DECK revenue for 2025-03-31 was $4.99B. Net income was $966.1M. Revenue was up 419.5% from 2024-03-31 to 2025-03-31. DECK currently screens at market cap $15.23B and trailing P/E 16.1.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. DECK currently screens at market cap $15.23B and trailing P/E 16.1.
Not investment advice. Open the BMRN and DECK stock pages for the full models.
Not investment advice.